Condition
Tenecteplase
Total Trials
6
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (3)
Trial Status
Recruiting4
Not Yet Recruiting1
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07475949Phase 3Recruiting
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
NCT07475936Recruiting
Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke
NCT07357987Phase 3Recruiting
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07168278Phase 3Not Yet Recruiting
Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
NCT06621121Recruiting
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke
NCT05580822Phase 2Unknown
Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion
Showing all 6 trials